| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 673* | 2014 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 363 | 2022 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 318 | 2017 |
| Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe H Fraser, NK Martin, H Brummer-Korvenkontio, P Carrieri, O Dalgard, ... Journal of hepatology 68 (3), 402-411, 2018 | 152 | 2018 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 143 | 2015 |
| Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis C Arum, H Fraser, AA Artenie, S Bivegete, A Trickey, M Alary, ... The Lancet public health 6 (5), e309-e323, 2021 | 139 | 2021 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 93 | 2015 |
| Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990–2014 DK Van Santen, JJ Van Der Helm, J Del Amo, L Meyer, ADA Monforte, ... Journal of hepatology 67 (2), 255-262, 2017 | 85 | 2017 |
| The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM SH Mooij, DK Van Santen, RB Geskus, MAB Van Der Sande, ... Aids 30 (1), 121-132, 2016 | 67 | 2016 |
| Cost-effectiveness of hepatitis C treatment for people who inject drugs and the impact of the type of epidemic; extrapolating from Amsterdam, the Netherlands DK van Santen, AS de Vos, A Matser, SB Willemse, K Lindenburg, ... PloS one 11 (10), e0163488, 2016 | 54 | 2016 |
| Microelimination of hepatitis C among people with human immunodeficiency virus coinfection: declining incidence and prevalence accompanying a multicenter treatment scale-up trial JS Doyle, DK van Santen, D Iser, J Sasadeusz, M O’Reilly, B Harney, ... Clinical Infectious Diseases 73 (7), e2164-e2172, 2021 | 32 | 2021 |
| The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms SB Willemse, D Razavi-Shearer, FR Zuure, IK Veldhuijzen, EA Croes, ... Neth J Med 73 (9), 417-31, 2015 | 28 | 2015 |
| Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis A Artenie, J Stone, H Fraser, D Stewart, C Arum, AG Lim, AL McNaughton, ... The lancet Gastroenterology & hepatology 8 (6), 533-552, 2023 | 25 | 2023 |
| The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the … DK van Santen, A Boyd, A Matser, L Maher, M Hickman, S Lodi, M Prins Addiction 116 (11), 3115-3126, 2021 | 25 | 2021 |
| HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985–2015 DK van Santen, JJ van der Helm, K Lindenburg, MS van der Loeff, ... International Journal of Drug Policy 47, 95-101, 2017 | 23 | 2017 |
| Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019 DK van Santen, R Sacks-Davis, A Stewart, A Boyd, J Young, ... EClinicalMedicine 56, 2023 | 22 | 2023 |
| The incidence of hepatitis C among gay, bisexual, and other men who have sex with men in Australia, 2009–2019 BL Harney, R Sacks-Davis, DK Van Santen, M Traeger, AL Wilkinson, ... Clinical Infectious Diseases 74 (10), 1804-1811, 2022 | 18 | 2022 |
| Does provider-initiated HIV testing and counselling lead to higher HIV testing rate and HIV case finding in Rwandan clinics? FR Kayigamba, D Van Santen, MI Bakker, J Lammers, V Mugisha, ... BMC Infectious Diseases 16, 1-9, 2015 | 18 | 2015 |
| Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status DK Van Santen, JJ van der Helm, BPX Grady, AS de Vos, ... Aids 28 (17), 2589-2599, 2014 | 18 | 2014 |
| The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services MW Traeger, AE Pedrana, DK Van Santen, JS Doyle, J Howell, ... PLoS One 15 (6), e0235445, 2020 | 17 | 2020 |
